SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing significant volatility and upward momentum driven by intense short-squeeze dynamics, with investors closely watching a recent SEC filing regarding executive change-of-control agreements as a potential precursor to a buyout. The community is heavily focused on the scarcity of available shares, high borrow rates, and the anticipation of topline results from the Phase 3 REGAL trial for their lead AML immunotherapy.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is seeing heavy community debate as investors weigh the stock's multi-year lows against potential catalysts like tariff refunds and an upcoming leadership transition. While some traders are betting on a turnaround ahead of earnings, others remain cautious of structural issues and negative analyst sentiment.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is currently seeing high volatility and intense community discussion as investors weigh promising Ibsrela growth and strong fundamentals against persistent legal and reimbursement headwinds from the CMS bundling dispute. While some shareholders remain bullish on the long-term potential for profitability and acquisition, others are expressing frustration over stagnant price action and the ongoing regulatory uncertainty.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors react to a significant strategic agreement with Fit Energy to provide up to 380 megawatts of clean, on-site power for AI data centers. The community remains sharply divided between bulls pointing to the growing proposal pipeline and data center demand, and skeptics who are raising concerns over warrant structures, potential shareholder dilution, and the opacity of the partner involved.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following news that the FDA has scheduled an advisory committee meeting for its DMD therapy, a development that triggered short-term volatility as traders de-risked ahead of the upcoming decision date. Despite the market's reaction, the community remains heavily focused on the company's strong five-year clinical data, viewing the meeting as a potential opportunity to secure a broader product label rather than a sign of rejection.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently seeing intense community debate and volatility, driven by ongoing efforts to position its solid oxide fuel cell technology as a critical, on-site energy solution for power-hungry AI data centers. Investors remain sharply divided between those viewing recent pullbacks as a buying opportunity based on long-term AI infrastructure backlogs and those expressing skepticism over the stock's valuation, share dilution, and the competitive threat from other energy alternatives.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as retail investors engage in a heated debate over the company's lack of upward price momentum and delayed relisting plans despite aggressive store expansion and strong operational metrics. The community is actively tracking potential corporate maneuvers, including strategic buybacks and international growth efforts, while speculating on the timing of a return to major exchanges.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is experiencing heightened volatility and investor speculation as the market anticipates the potential allocation of FDA priority vouchers following recent executive orders supporting psychedelic therapy. The community is closely monitoring trial milestones for lead assets like BPL-003 and actively debating the stock's valuation disconnect and potential for a strategic partnership or buyout.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending as investors react to a new $6 billion share repurchase program, signaling management's confidence despite ongoing cyclical pressures in automotive and industrial markets. The community remains focused on the stock's potential for a long-term rebound, closely monitoring its performance as it navigates support levels and potential technical breakouts.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant volatility driven by the positive reception of its long-term oncology trial data and a fresh FDA endorsement for its mRNA-based influenza vaccine candidate. While shareholders and the community are actively debating the company's transition beyond COVID-19 and the potential for a short squeeze, some remain skeptical, citing persistent concerns over regulatory headwinds and the long-term commercialization strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PICS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds PicS N.V. (PICS) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

PICS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds PicS N.V. (PICS) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026 PICS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds PicS N.V. (PICS) Investors of Securities Class Action Lawsuit Deadline on August 4...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PicS N.V. of Class Action Lawsuit and Upcoming Deadlines - PICS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PicS N.V. of Class Action Lawsuit and Upcoming Deadlines - PICS INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PicS N.V. of Class Action Lawsuit and Upcoming Deadlines...

PicS N.V. (PICS) Faces Securities Class Action Related to IPO Omissions Regarding Credit Procedures and Quality - HBSS

PicS N.V. (PICS) Faces Securities Class Action Related to IPO Omissions Regarding Credit Procedures and Quality - HBSS PicS N.V. (PICS) Faces Securities Class Action Related to IPO Omissions Regarding Credit Procedures and Quality - HBSS PR Newswire SAN FRANCISCO, June 25, 2026 SAN FRANCISCO, June...

INVESTOR DEADLINE ALERT: PicS N.V. (NASDAQ: PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

INVESTOR DEADLINE ALERT: PicS N.V. (NASDAQ: PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit INVESTOR DEADLINE ALERT: PicS N.V. (NASDAQ: PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire RADNOR, Pa., June 24, 2026...

PICS INVESTOR DEADLINE: PicS N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

PICS INVESTOR DEADLINE: PicS N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit PICS INVESTOR DEADLINE: PicS N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit PR Newswire SAN DIEGO, June 24, 2026 SAN DIEGO, June...

PicS N.V. (PICS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

PicS N.V. (PICS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PicS N.V. (PICS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS ANGELES, June 24, 2026 LOS ANGELES, June 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke...

Lost Money on PicS N.V. (PICS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Lost Money on PicS N.V. (PICS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky Lost Money on PicS N.V. (PICS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PR Newswire NEW YORK, June 24, 2026 Time-Sensitive: Allegations Focus on Undisclosed Stage 3...

PICS Deadline Alert: The Gross Law Firm Reminds PicS N.V. (PICS) Investors of Securities Class Action Deadline on August 4, 2026

PICS Deadline Alert: The Gross Law Firm Reminds PicS N.V. (PICS) Investors of Securities Class Action Deadline on August 4, 2026 PICS Deadline Alert: The Gross Law Firm Reminds PicS N.V. (PICS) Investors of Securities Class Action Deadline on August 4, 2026 PR Newswire NEW YORK, June 23, 2026 NEW...

PICS Investors Have Opportunity to Lead PicS N.V. Securities Lawsuit

PICS Investors Have Opportunity to Lead PicS N.V. Securities Lawsuit PICS Investors Have Opportunity to Lead PicS N.V. Securities Lawsuit PR Newswire NEW YORK, June 22, 2026 NEW YORK, June 22, 2026 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on...

Rosen Law Firm Urges PicS N.V. (NASDAQ: PICS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of PicS N.V. (NASDAQ: PICS) Class A common stock pursuant and/or traceable to PicS January 30, 2026 initial public offering (the IPO). PicS operates a digital bank in Brazil.For more information...

PicS NV engages in the provision of financial services. It operates through the following segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The Consumer Banking segment includes digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments. The Small and Medium-Sized Businesses segment encompasses merchant-discount rates (MDR) charged to merchants accepting PicPay as a payment network. The Audiences and Ecosystem Integration segment offers services to customers, which include consumers and businesses, and is essential to increase engagement and monetization of both sides of the ecosystem. The Institutional segment refers to revenue, costs, and expenses from financial investments and funding activities executed at the corporate level. The company was founded by Anderson Chamon in 2012 and is headquartered in São Paulo, Brazil.

PicS N.V. - Ordinary Shares - Class A

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$10.13
Prev Close	$9.92
Open	$9.90
Dividend Yield	N/A
50-Day Moving Average	$11.33
Beta	2.63
Avg. Volume	331,221.97
PE Ratio	5,937.63

52-Week High	$19.95
52-Week Low	$8.32
Market Capitalization	$1.29B
EPS (Annual)	$0.0015
Price to Book	1.11
Revenue Per Employee	$465,530.76

Feed

News

Sentiment

Earnings

Fundamentals

Info

PICSPicS N.V. - Ordinary Shares - Class A

Latest PICS News